Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis

B. Baggio, A. Budakovic, M. A. Nassuato, G. Vezzoli, E. Manzato, G. Luisetto, M. Zaninotto

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background. Reports of an increase in plasma and erythrocyte phospholipid arachidonic acid content and in urinary prostaglandin E2 (PGE2) excretion in patients with idiopathic calcium nephrolithiasis suggested their crucial role in the pathogenesis of hypercalciuria, a well-known risk factor for lithogenesis. Methods. To confirm this hypothesis, 15 healthy subjects and 20 nephrolithiasis patients were evaluated for plasma phospholipid polyunsaturated fatty acid content and PGE2 concentration, serum parathyroid hormone, 25 hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, and bone-specific alkaline phosphatase levels, as well as urinary excretion of calcium, biochemical markers of bone resorption (hydroxyproline and crossLaps), and intestinal calcium absorption. Furthermore, the effect of a 30-day fish-oil diet supplementation on the previously mentioned parameters was investigated in the patients. Results. At baseline, patients compared with controls showed higher levels of plasma phospholipid arachidonic acid content (P = 0.002), PGE2 (P = 0.0004), serum 25-vitamin D3 (P = 0.001), and 1,25-vitamin D3 (P = 0.001), urinary excretion of calcium (P = 0.001), hydroxyproline (P = 0.007), and crossLaps (P = 0.019), as well as intestinal calcium absorption (P = 0.03 at 60 min). Fish oil supplementation induced a reduction in the plasma phospholipid arachidonic acid level (P <0.0001), and except for serum concentrations of 25-vitamin D3, normalized baseline blood and urinary parameters, including intestinal calcium absorption. A close correlation between plasma PGE2 and serum 1,25-vitamin D3 (P = 0.004) and between phospholipid arachidonic acid and intestinal calcium absorption (P = 0.0002) and calciuria (P = 0.007) was observed, as well as between urine excretion of crossLaps and hydroxyproline (P <0.0001), crossLaps and calcium (P <0.0001), and hydroxyproline and calcium (P <0.0001). Conclusions. These findings indicate that the phospholipid arachidonic acid content anomaly could represent the primary event responsible for the mosaic of metabolic and clinical alterations that are distinctive features of renal stone formers, and suggest that a common pathogenetic mechanism might account for the several forms of hypercalciuria detected in idiopathic calcium nephrolithiasis.

Original languageEnglish
Pages (from-to)1278-1284
Number of pages7
JournalKidney International
Volume58
Issue number3
DOIs
Publication statusPublished - 2000

Fingerprint

Nephrolithiasis
Arachidonic Acid
glutamyl-lysyl-alanyl-histidyl-aspartyl-glycyl-glycyl-arginine
Phospholipids
Calcium
Cholecalciferol
Hydroxyproline
Intestinal Absorption
Dinoprostone
Hypercalciuria
Fish Oils
Serum
Calcifediol
Calcitriol
Bone Resorption
Parathyroid Hormone
Unsaturated Fatty Acids
Alkaline Phosphatase
Healthy Volunteers
Erythrocytes

Keywords

  • Calciotropic hormones
  • Hypercalciuria
  • Kidney stones
  • Lithogenesis
  • Renal stone formers

ASJC Scopus subject areas

  • Nephrology

Cite this

Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. / Baggio, B.; Budakovic, A.; Nassuato, M. A.; Vezzoli, G.; Manzato, E.; Luisetto, G.; Zaninotto, M.

In: Kidney International, Vol. 58, No. 3, 2000, p. 1278-1284.

Research output: Contribution to journalArticle

Baggio, B. ; Budakovic, A. ; Nassuato, M. A. ; Vezzoli, G. ; Manzato, E. ; Luisetto, G. ; Zaninotto, M. / Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. In: Kidney International. 2000 ; Vol. 58, No. 3. pp. 1278-1284.
@article{f3f654d63c3943e69a1fbb3749806270,
title = "Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis",
abstract = "Background. Reports of an increase in plasma and erythrocyte phospholipid arachidonic acid content and in urinary prostaglandin E2 (PGE2) excretion in patients with idiopathic calcium nephrolithiasis suggested their crucial role in the pathogenesis of hypercalciuria, a well-known risk factor for lithogenesis. Methods. To confirm this hypothesis, 15 healthy subjects and 20 nephrolithiasis patients were evaluated for plasma phospholipid polyunsaturated fatty acid content and PGE2 concentration, serum parathyroid hormone, 25 hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, and bone-specific alkaline phosphatase levels, as well as urinary excretion of calcium, biochemical markers of bone resorption (hydroxyproline and crossLaps), and intestinal calcium absorption. Furthermore, the effect of a 30-day fish-oil diet supplementation on the previously mentioned parameters was investigated in the patients. Results. At baseline, patients compared with controls showed higher levels of plasma phospholipid arachidonic acid content (P = 0.002), PGE2 (P = 0.0004), serum 25-vitamin D3 (P = 0.001), and 1,25-vitamin D3 (P = 0.001), urinary excretion of calcium (P = 0.001), hydroxyproline (P = 0.007), and crossLaps (P = 0.019), as well as intestinal calcium absorption (P = 0.03 at 60 min). Fish oil supplementation induced a reduction in the plasma phospholipid arachidonic acid level (P <0.0001), and except for serum concentrations of 25-vitamin D3, normalized baseline blood and urinary parameters, including intestinal calcium absorption. A close correlation between plasma PGE2 and serum 1,25-vitamin D3 (P = 0.004) and between phospholipid arachidonic acid and intestinal calcium absorption (P = 0.0002) and calciuria (P = 0.007) was observed, as well as between urine excretion of crossLaps and hydroxyproline (P <0.0001), crossLaps and calcium (P <0.0001), and hydroxyproline and calcium (P <0.0001). Conclusions. These findings indicate that the phospholipid arachidonic acid content anomaly could represent the primary event responsible for the mosaic of metabolic and clinical alterations that are distinctive features of renal stone formers, and suggest that a common pathogenetic mechanism might account for the several forms of hypercalciuria detected in idiopathic calcium nephrolithiasis.",
keywords = "Calciotropic hormones, Hypercalciuria, Kidney stones, Lithogenesis, Renal stone formers",
author = "B. Baggio and A. Budakovic and Nassuato, {M. A.} and G. Vezzoli and E. Manzato and G. Luisetto and M. Zaninotto",
year = "2000",
doi = "10.1046/j.1523-1755.2000.00283.x",
language = "English",
volume = "58",
pages = "1278--1284",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis

AU - Baggio, B.

AU - Budakovic, A.

AU - Nassuato, M. A.

AU - Vezzoli, G.

AU - Manzato, E.

AU - Luisetto, G.

AU - Zaninotto, M.

PY - 2000

Y1 - 2000

N2 - Background. Reports of an increase in plasma and erythrocyte phospholipid arachidonic acid content and in urinary prostaglandin E2 (PGE2) excretion in patients with idiopathic calcium nephrolithiasis suggested their crucial role in the pathogenesis of hypercalciuria, a well-known risk factor for lithogenesis. Methods. To confirm this hypothesis, 15 healthy subjects and 20 nephrolithiasis patients were evaluated for plasma phospholipid polyunsaturated fatty acid content and PGE2 concentration, serum parathyroid hormone, 25 hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, and bone-specific alkaline phosphatase levels, as well as urinary excretion of calcium, biochemical markers of bone resorption (hydroxyproline and crossLaps), and intestinal calcium absorption. Furthermore, the effect of a 30-day fish-oil diet supplementation on the previously mentioned parameters was investigated in the patients. Results. At baseline, patients compared with controls showed higher levels of plasma phospholipid arachidonic acid content (P = 0.002), PGE2 (P = 0.0004), serum 25-vitamin D3 (P = 0.001), and 1,25-vitamin D3 (P = 0.001), urinary excretion of calcium (P = 0.001), hydroxyproline (P = 0.007), and crossLaps (P = 0.019), as well as intestinal calcium absorption (P = 0.03 at 60 min). Fish oil supplementation induced a reduction in the plasma phospholipid arachidonic acid level (P <0.0001), and except for serum concentrations of 25-vitamin D3, normalized baseline blood and urinary parameters, including intestinal calcium absorption. A close correlation between plasma PGE2 and serum 1,25-vitamin D3 (P = 0.004) and between phospholipid arachidonic acid and intestinal calcium absorption (P = 0.0002) and calciuria (P = 0.007) was observed, as well as between urine excretion of crossLaps and hydroxyproline (P <0.0001), crossLaps and calcium (P <0.0001), and hydroxyproline and calcium (P <0.0001). Conclusions. These findings indicate that the phospholipid arachidonic acid content anomaly could represent the primary event responsible for the mosaic of metabolic and clinical alterations that are distinctive features of renal stone formers, and suggest that a common pathogenetic mechanism might account for the several forms of hypercalciuria detected in idiopathic calcium nephrolithiasis.

AB - Background. Reports of an increase in plasma and erythrocyte phospholipid arachidonic acid content and in urinary prostaglandin E2 (PGE2) excretion in patients with idiopathic calcium nephrolithiasis suggested their crucial role in the pathogenesis of hypercalciuria, a well-known risk factor for lithogenesis. Methods. To confirm this hypothesis, 15 healthy subjects and 20 nephrolithiasis patients were evaluated for plasma phospholipid polyunsaturated fatty acid content and PGE2 concentration, serum parathyroid hormone, 25 hydroxyvitamin D3, 1,25-dihydroxyvitamin D3, and bone-specific alkaline phosphatase levels, as well as urinary excretion of calcium, biochemical markers of bone resorption (hydroxyproline and crossLaps), and intestinal calcium absorption. Furthermore, the effect of a 30-day fish-oil diet supplementation on the previously mentioned parameters was investigated in the patients. Results. At baseline, patients compared with controls showed higher levels of plasma phospholipid arachidonic acid content (P = 0.002), PGE2 (P = 0.0004), serum 25-vitamin D3 (P = 0.001), and 1,25-vitamin D3 (P = 0.001), urinary excretion of calcium (P = 0.001), hydroxyproline (P = 0.007), and crossLaps (P = 0.019), as well as intestinal calcium absorption (P = 0.03 at 60 min). Fish oil supplementation induced a reduction in the plasma phospholipid arachidonic acid level (P <0.0001), and except for serum concentrations of 25-vitamin D3, normalized baseline blood and urinary parameters, including intestinal calcium absorption. A close correlation between plasma PGE2 and serum 1,25-vitamin D3 (P = 0.004) and between phospholipid arachidonic acid and intestinal calcium absorption (P = 0.0002) and calciuria (P = 0.007) was observed, as well as between urine excretion of crossLaps and hydroxyproline (P <0.0001), crossLaps and calcium (P <0.0001), and hydroxyproline and calcium (P <0.0001). Conclusions. These findings indicate that the phospholipid arachidonic acid content anomaly could represent the primary event responsible for the mosaic of metabolic and clinical alterations that are distinctive features of renal stone formers, and suggest that a common pathogenetic mechanism might account for the several forms of hypercalciuria detected in idiopathic calcium nephrolithiasis.

KW - Calciotropic hormones

KW - Hypercalciuria

KW - Kidney stones

KW - Lithogenesis

KW - Renal stone formers

UR - http://www.scopus.com/inward/record.url?scp=0033863337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033863337&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2000.00283.x

DO - 10.1046/j.1523-1755.2000.00283.x

M3 - Article

VL - 58

SP - 1278

EP - 1284

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -